Latest Breaking News On - Maeve conneighton - Page 1 : comparemela.com

Applied Therapeutics Reports First Quarter 2024 Financial Results

Applied Therapeutics Reports First Quarter 2024 Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Shoshana shendelmanAdvanz pharmaMaeve conneightonCommittee for medicinal products human useDrug administrationJournal of the american college cardiologyAmerican college of cardiologyTherapeutics incNeurologyi divisionAmerican college of cardiology annual scientific sessionNeurology divisionEuropean medicines agencyExchange commissionClassic galactosemiaPriority reviewAccelerated approval

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMaeve conneightonNasriene ibrahimJamesl januzzi jrThomash marwickGregoryd lewisRiccardo perfettiJustina ezekowitzFaiez zannadAdvanz pharmaJaved butlerWh wilson tangJulio rosenstockTherapeutics incJournal of the american college cardiologyExchange commission

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia

NEW YORK, March 28, 2024 Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications.

Advanz pharmaMaeve conneightonShoshana shendelmanExchange commissionCommittee for medicinal products human useEuropean medicines agencyDrug administrationHealth indexTherapeutics incNew drug applicationClassic galactosemiaPrescription drug user fee actApplied therapeuticsMajor amendmentPriority reviewPediatric rare disease

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Advanz pharmaShoshana shendelmanMaeve conneightonDrug administrationHealth indexCommittee for medicinal products human useEuropean medicines agencyTherapeutics incExchange commissionAction dateNew drug applicationClassic galactosemiaPrescription drug user fee actApplied therapeuticsMajor amendmentPriority review

Applied Therapeutics Announces $100 Million Private Placement

Applied Therapeutics Announces $100 Million Private Placement
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMaeve conneightonAdvanz pharmaExchange commissionFrazier life sciencesInvestment bankTherapeutics incMeagher flomTherapeutics announcesPrivate placementPerceptive advisorsJanus henderson investorsVenrock healthcare capital partnersAdage capital partnersLogos capitalVestal point capital